Labcorp Holdings Inc. (LH) stock price, financials & research

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

68/ 100

GoAI Score

Buy

Valuation

93

Deep Value

Sentiment

51

Mixed

Risk

20

Low Risk

Momentum

45

Neutral

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Industry: Medical - Diagnostics & Research
Sector: Healthcare
Headquarters: US
CEO: Adam H. Schechter
Listed since: Mar 29, 1990
Employees: 71,000

Market position

Day range

Current $312.15

$311.62$318.18

52-week range

Current $312.15

$244.52$341.8

Open: $313.39
Previous close: $314.2
Volume: 607.85K; 0.86× average
Average volume: 709.96K; Average daily volume
Market cap: 25.6B USD
Beta: 0.85; Market reference 1
50-day average: $319.83; -2.40% below average
200-day average: $281.78; +10.78% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 27.54B USD
EV / EBITDA: 13.69×
Earnings yield: 4.20%
Free cash flow yield: 5.78%

Profitability & efficiency

Return on equity: 10.17%
Return on assets: 4.77%
Return on invested capital: 7.39%

Financial health

Current ratio: 1.42×
Altman Z-score: 3.35
Piotroski F-score: 8 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

13.95B USD+7.25%

Operating income

1.52B USD+39.52%

Net income

876.5M USD+17.49%

Financial statements: Income statement
Metric (USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	13.95B USD	13.01B USD	12.16B USD	11.86B USD	13.14B USD
Cost of goods sold	10.22B USD	9.38B USD	8.8B USD	8.16B USD	8.14B USD
Gross profit	3.73B USD	3.62B USD	3.36B USD	3.71B USD	4.99B USD
Research and development	—	—	2M USD	—	—
Selling, general, and administrative	2.22B USD	2.23B USD	2.02B USD	2B USD	1.69B USD
Operating expenses	2.22B USD	2.54B USD	2.64B USD	2.27B USD	1.94B USD
Interest income	15.2M USD	—	—	—	—
Interest expense	224.1M USD	208.3M USD	199.6M USD	179.8M USD	211.8M USD
Depreciation and amortization	681.1M USD	643.5M USD	577.3M USD	537.2M USD	577M USD
Operating income	1.52B USD	1.09B USD	725.6M USD	1.44B USD	3.05B USD
Net income	876.5M USD	746M USD	418M USD	1.28B USD	2.38B USD

Company facts updated Oct 11, 2026.

Earnings

EPS beat rate: 100%; 11 beats, 0 misses, 0 met estimates
Average EPS surprise: +2.91%; 11 comparable reports
Latest EPS result: 4.99; Estimate 4.78 · Beat by 4.39%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Latest fiscal-year EPS: 10.46; FY2025 · +18.33% year over year
Latest fiscal-year revenue: 13.95B USD; FY2025 · +7.25% year over year
Next fiscal-year EPS consensus: 18.35; FY2026 · 10 analysts
Next fiscal-year revenue consensus: 14.75B USD; FY2026 · 8 analysts

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Recent analyst actions

12 institutions

LH news

zacks.comOct 6, 2026

Here's Why Labcorp Holdings (LH) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read source

prnewswire.comSep 30, 2026

Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026

BURLINGTON, N.C., Sept. 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc.

Read source

zacks.comSep 29, 2026

Is This the Right Time to Add Labcorp Stock to Your Portfolio?

LH expands specialty testing and consumer services through acquisitions, partnerships and AI, while reimbursement and cost risks remain.

Read source

defenseworld.netSep 24, 2026

Labcorp (NYSE:LH) Shares Gap Down – Should You Sell?

Labcorp Holdings Inc. (NYSE: LH - Get Free Report) shares gapped down prior to trading on Tuesday. The stock had previously closed at $320.99, but opened at $303.46. Labcorp shares last traded at $313.95, with a volume…

Read source

defenseworld.netSep 24, 2026

Critical Survey: HCA Healthcare (NYSE:HCA) and Labcorp (NYSE:LH)

HCA Healthcare (NYSE: HCA - Get Free Report) and Labcorp (NYSE: LH - Get Free Report) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of…

Read source

seekingalpha.comSep 23, 2026

Labcorp: The CMS Selloff Represents An Excellent Opportunity - Strong Buy

Labcorp shares dropped sharply after CMS released preliminary 2027 lab-payment rates, aligning Medicare rates closer to private insurers and targeting $1B annual savings. I see the selloff as overdone, with market fears…

Read source

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$2.88

2025 complete year+252.9% since 1992

2026 partial: $2.16

$0.8161

1,992

$0.6873

1,993

$2.6771

2,023

$2.88

2,024

$2.88

2,025

$2.16

2,026*

* Partial calendar year in the available dividend history.

Corporate action history

Action	Ex-dividend date	Details	Record date	Payment date
Dividend	Aug 28, 2026	$0.72Quarterly	Aug 28, 2026	Sep 11, 2026
Dividend	May 29, 2026	$0.72Quarterly	May 29, 2026	Jun 11, 2026
Dividend	Feb 27, 2026	$0.72Quarterly	Feb 27, 2026	Mar 12, 2026
Dividend	Nov 26, 2025	$0.72Quarterly	Nov 26, 2025	Dec 11, 2025
Dividend	Aug 28, 2025	$0.72Quarterly	Aug 28, 2025	Sep 11, 2025
Dividend	May 29, 2025	$0.72Quarterly	May 29, 2025	Jun 11, 2025